Solute Carrier Family 30 Member 8 Gene 807C/T Polymorphism and Type 2 Diabetes Mellitus in the Chinese Population: A Meta-Analysis Including 6,942 Subjects
Although gene 807C/T polymorphism is associated with an increased risk of type 2 diabetes mellitus (T2DM) risk, there remains some inconsistency between individual studies. The aim of the study is to explore the relationship between gene 807C/T polymorphism and T2DM in the Chinese population. The cu...
Saved in:
Published in | Frontiers in endocrinology (Lausanne) Vol. 9; p. 263 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
23.05.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Although
gene 807C/T polymorphism is associated with an increased risk of type 2 diabetes mellitus (T2DM) risk, there remains some inconsistency between individual studies.
The aim of the study is to explore the relationship between
gene 807C/T polymorphism and T2DM in the Chinese population.
The current meta-analysis compiles and analyzes the data of 6,942 participants from 10 independent studies. Either a fixed or random-effects model was adopted to evaluate the pooled odds ratio (ORs) and the corresponding 95% confidence interval (95% CI).
A significant association between
gene 807C/T polymorphism and T2DM was found in the Chinese population under allelic (OR: 0.85, 95% CI: 0.80-0.91,
= 7.42 × 10
), recessive (OR: 0.52, 95% CI: 0.38-0.72,
= 8.49 × 10
), dominant (OR: 2.40, 95% CI: 1.68-3.41,
= 1.30 × 10
), homozygous (OR: 0.52, 95% CI: 0.40-0.67,
= 2.90 × 10
), heterozygous (OR: 0.79, 95% CI: 0.71-0.88,
= 1.63 × 10
), and additive genetic models (OR: 0.73, 95% CI: 0.64-0.83,
= 7.05 × 10
).
gene 807C/T polymorphism was significantly associated with an increased T2DM risk in the Chinese population. Therefore, individuals of Chinese descent with the C allele of
gene 807C/T polymorphism may be more susceptible to developing T2DM, while individuals with the T allele may be protected against T2DM. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Ondřej Šeda, Charles University, Czechia Reviewed by: Hidetaka Hamasaki, Hamasaki Clinic, Japan; Wensheng Pan, Zhejiang Provincial People’s Hospital, China Specialty section: This article was submitted to Diabetes, a section of the journal Frontiers in Endocrinology These authors have contributed equally to this work. |
ISSN: | 1664-2392 1664-2392 |
DOI: | 10.3389/fendo.2018.00263 |